SCHEMBL22945149

SCHEMBL22945149

Cc1ccc(C(C(=O)Nc2nccs2)C(C)C)cc1

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FFAR2 O15552 7/20 0.79
▸ LMNA P02545 3/20 0.79
▸ MEN1 O00255 1/20 0.79
▸ KMT2A Q03164 1/20 0.79
▸ TSHR P16473 1/20 0.78
▸ NPC1 O15118 2/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ XBP1 P17861 1/20 0.55
▸ HTT P42858 2/20 0.54
▸ GAA P10253 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ HSPA9 P38646 3/20 0.51
▸ HSPA5 P11021 2/20 0.51
▸ HSPA2 P54652 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16369642 0.88 FFAR2 (1.00) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL16369644 0.88 FFAR2 (1.00) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL1107000 0.76 ADORA2A (0.68) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL8246090 0.75 LMNA (0.59) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL1565491 0.74 NPC1 (0.54) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL1564845 0.74 LMNA (0.69) FFAR2LMNAMEN1KMT2ANPC1
SCHEMBL23804604 0.74 LMNA (0.59) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL7876872 0.74 LMNA (0.59) FFAR2LMNAMEN1KMT2ATSHR
Bromide SCHEMBL11310364 0.74 LMNA (0.58) FFAR2LMNAMEN1KMT2ATSHR
SCHEMBL3223685 0.74 RAB9A (1.00) LMNAMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021018786-A1 USE OF FFAR2 AGONISTS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-VIRAL INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2021-02-04 — — WO disclosed
Send feedback